|
Volumn 483, Issue 7389, 2012, Pages 267-268
|
Plug the real brain drain
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NOGO A ANTIBODY;
PROTEIN NOGO A;
ALZHEIMER DISEASE;
AMYOTROPHIC LATERAL SCLEROSIS;
BRAIN INJURY;
CLINICAL RESEARCH;
CLINICAL TRIAL (TOPIC);
COMPETITIVE INHIBITION;
DRUG INDUSTRY;
HEALTH CARE COST;
HUMAN;
NEUROLOGIC DISEASE;
NEUROPROTECTION;
NONHUMAN;
NOTE;
PARALYSIS;
PARKINSON DISEASE;
PRIORITY JOURNAL;
SPINAL CORD INJURY;
STROKE;
ANIMAL;
ARTICLE;
CENTRAL NERVOUS SYSTEM DISEASE;
DRUG EFFECT;
ECONOMICS;
MALE;
MEDICAL RESEARCH;
METHODOLOGY;
NERVE REGENERATION;
NEUROSCIENCE;
ORGANIZATION AND MANAGEMENT;
PATHOPHYSIOLOGY;
PERSONALIZED MEDICINE;
PHYSIOLOGY;
PREVALENCE;
STATISTICS;
TRANSLATIONAL RESEARCH;
ANIMALS;
BIOMEDICAL RESEARCH;
CENTRAL NERVOUS SYSTEM DISEASES;
CLINICAL TRIALS AS TOPIC;
DRUG INDUSTRY;
HEALTH CARE COSTS;
HUMANS;
INDIVIDUALIZED MEDICINE;
MALE;
NERVE REGENERATION;
NEUROSCIENCES;
PREVALENCE;
SPINAL CORD INJURIES;
STROKE;
TRANSLATIONAL MEDICAL RESEARCH;
|
EID: 84858264245
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/483267a Document Type: Note |
Times cited : (10)
|
References (7)
|